Trial
NCT01911416
A Biomarker Study to Identify Predictive Signatures of Response to LDE225 (Hedgehog Inhibitor) In Patients With Resectable Pancreatic Cancer
UnknownWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Utah
Collaborators
—
Condition
Pancreatic Ductal Adenocarcinoma
Intervention
LDE225
Why stopped
No accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-06-09